Pet Allergy Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Drug Class (Antihistamines, Corticosteroids, Immunotherapy, Other Drug Classes); Pet Type (Dogs, Cats, Rabbits, Other Pet Types); Route of Administration (Oral, Injectable, Topical); and Geography (North America, Europe, Asia Pacific, and South and Central America)

The Pet Allergy Market is expected to register a CAGR of 8.9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented By Drug Class (Antihistamines, Corticosteroids, Immunotherapy, and Other Drug Classes), Pet Type (Dogs, Cats, Rabbits, and Other Pet Types), Route of Administration (Oral, Injectable, and Topical). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Pet Allergy Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

• Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
• Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
• Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Pet Allergy Market Segmentation

Drug Class

• Antihistamines
• Corticosteroids
• Immunotherapy
• Other Drug Classes

Pet Type

• Dogs
• Cats
• Rabbits
• Other Pet Types

Route of Administration

• Oral
• Injectable
• Topical

Pet Allergy Market Growth Drivers

• Increasing Pet Ownership: The rising trend of pet ownership worldwide is a key driver for the pet allergy market. As more households adopt pets, particularly dogs and cats, the number of people exposed to allergens from pet dander and saliva increases. This leads to a higher prevalence of pet allergies, fueling the demand for diagnostic tests, treatments, and allergy management solutions.
• Growing Awareness and Diagnosis of Allergies: As awareness of allergies and their symptoms grows, more individuals are seeking diagnosis and treatment for pet allergies. Increased public education on the health risks associated with pet dander, along with better diagnostic tools, is leading more people to recognize and address their symptoms. This heightened awareness is driving the demand for allergy medications and specialized treatments for pet allergies.
• Advancements in Allergy Treatments and Immunotherapy: Advancements in allergy treatments, including immunotherapy and biologic therapies, are driving the pet allergy market. These new treatments offer more effective solutions for managing and desensitizing patients to pet allergens. As these therapies become more widely available and offer improved results, more people are opting for long-term relief from pet allergies, contributing to market growth.

Pet Allergy Market Future Trends

• Rise of Allergy-Friendly Pets: A growing trend in the pet allergy market is the increased popularity of hypoallergenic or allergy-friendly pets. Breeds that produce fewer allergens, such as certain dog or cat breeds, are becoming more sought after by individuals with sensitivities to pet dander. This trend is influencing pet owners to seek pets that minimize allergic reactions, impacting demand for specific pet breeds.
• Use of Air Purifiers and Allergen-Reducing Products: Another trend is the increasing use of air purifiers, specialized cleaning products, and allergen-reducing shampoos to manage pet allergies. These products help reduce airborne allergens, providing allergy sufferers with relief. As awareness of pet allergens rises, pet owners are turning to these products to create a safer, more comfortable living environment, driving growth in the market for allergen-reducing solutions.
• Shift Towards Biologic Treatments: The shift towards biologic treatments in the pet allergy market is gaining traction. Biologics, such as monoclonal antibodies, offer more targeted therapies to treat pet allergies by reducing the body’s allergic response to specific allergens. This trend towards precision medicine is improving the effectiveness of treatment options, making biologic therapies an attractive choice for those with severe pet allergies.

Pet Allergy Market Opportunities

• Development of Allergen-Free Pet Products: There is a growing opportunity to develop and market allergen-free pet products, such as grooming products, shampoos, and bedding that reduce dander and allergens. These products cater to consumers who are sensitive to pet allergies but still want to keep pets. Companies can capitalize on this demand by creating innovative solutions to help manage allergies while maintaining pet ownership.
• Expansion of Allergy Immunotherapy Solutions: Immunotherapy treatments for pet allergies present a significant market opportunity. With advances in allergen-specific immunotherapy, including both allergy shots and sublingual tablets, individuals with severe pet allergies can now seek long-term solutions. Expanding access to these therapies, particularly in regions with rising pet ownership, can drive growth in the market for more effective, customized allergy management solutions.
• Collaboration with Pet Adoption Centers: Partnering with pet adoption centers and veterinary clinics offers an opportunity to promote allergy-friendly pets and treatments. By providing education on managing pet allergies, offering hypoallergenic pets, or recommending allergen-reducing products, companies can build brand awareness and tap into a larger consumer base. These partnerships can help drive both the adoption of pets and the use of allergy management products.

Pet Allergy Market Regional Insights

The regional trends and factors influencing the Pet Allergy Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Pet Allergy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Pet Allergy Market Report Scope

Pet Allergy Market Players Density: Understanding Its Impact on Business Dynamics

The Pet Allergy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Pet Allergy Market are:

1. Zoetis Animal Healthcare
2. Merck & Co. Inc.
3. Boehringer Ingelheim International GmbH
4. Elanco
5. Provetica LLC
6. Vetoquinol

Disclaimer: The companies listed above are not ranked in any particular order.

Key Selling Points

• Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pet Allergy Market, providing a holistic landscape.
• Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
• Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
• Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Pet Allergy Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

• Zoetis Animal Healthcare


• Merck & Co. Inc.


• Boehringer Ingelheim International GmbH


• Elanco


• Provetica LLC


• Vetoquinol


• Neogen Corporation


• Phibro Animal Health Corporation


• Dechra


• Virbac